Uncategorized Archives - Boston Life Sciences Times

Vyome Appoints Dr. Aditya Bardia as Senior Medical Advisor to Guide Development of MFW Program

November 25, 2025

Boston Life Sciences Times Announces 2025 Vanguard Award Winners

November 14, 2025

Mursla Bio Partners with Global Pharmaceutical Company to Advance Biomarker-Guided Precision Medicine in MASH

November 13, 2025

THIS WEEK'S STORIES

GE HealthCare Receives FDA Authorization for Deep-Learning Mammography Reconstruction Tool

November 26, 2025

Inflammasome Therapeutics Completes Enrollment of Phase II Study for Dual Inflammasome Inhibitor K8 to Treat Geographic Atrophy

November 25, 2025

AI Proteins Raises $41.5 Million Series A to Advance De Novo Miniprotein Medicines

November 19, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Uncategorized

LEO Pharma initiates head-to-head study to evaluate brodalumab vs. guselkumab in adult patients with moderate-to-severe psoriasis who have inadequate response to ustekinumab

Sigma Analytical Partners with Ecolab to Help Ensure Safe Production of Cannabis Products

Most Read

GE HealthCare Receives FDA Authorization for Deep-Learning Mammography Reconstruction Tool

Otsuka’s VOYXACT Wins FDA Accelerated Approval for IgA Nephropathy Proteinuria Reduction

Galux Reports AI Engine Produced High-Affinity Antibodies From Only 50 Designs

EdgeOne Medical Hires Industry Veteran Marty Shelton as Chief Operating Officer

EDITOR PICKS

Vyome Appoints Dr. Aditya Bardia as Senior Medical Advisor to Guide Development of MFW Program

Boston Life Sciences Times Announces 2025 Vanguard Award Winners

Mursla Bio Partners with Global Pharmaceutical Company to Advance Biomarker-Guided Precision Medicine in MASH

THIS WEEK'S STORIES

GE HealthCare Receives FDA Authorization for Deep-Learning Mammography Reconstruction Tool

Inflammasome Therapeutics Completes Enrollment of Phase II Study for Dual Inflammasome Inhibitor K8 to Treat Geographic Atrophy

AI Proteins Raises $41.5 Million Series A to Advance De Novo Miniprotein Medicines

POPULAR CATEGORY

ABOUT US

FOLLOW US

Uncategorized

No posts to display

Most Read

EDITOR PICKS

THIS WEEK'S STORIES

POPULAR CATEGORY

ABOUT US

FOLLOW US